Baruch Y, Holtom BC Survey response rate levels and trends in organizational research. Hum Relations 2008;61:1139-60. doi:10.1177/0018726708094863
Beebe L Supplemental materials for journal articles: NISO/NFAIS working group. Information Standards Quarterly 2010;22:33-7. doi:10 .3789/isqv22n3.2010.07
Cobanoglu C The effect of incentives in web surveys : application and ethical considerations. Int J Mark Res 2003;45:475-88.
Health_Research_Board_Trial MNM Education section - Studies Within A Trial (SWAT). J Evid Based Med 2012;5:44-5. doi:10.1111/j.1756-5391.2011.01169.x
Kenyon J, Sprague N, Flathers E The Journal Article as a Means to Share Data: a Content Analysis of Supplementary Materials from Two Disciplines. J Librarianship Scholarly Community 2016;4:eP2112. doi:10.7710/2162-3309.2112
Price A, Schroter S, Clarke M, McAneney H Role of supplementary material in biomedical journal articles: surveys of authors, reviewers and readers. BMJ Open. 2018 Sep 24;8(9):e021753. doi: 10.1136/bmjopen-2018-021753.
The Role of Supplementary Material in Journal Articles Surveys of Authors, Reviewers and Readers Questionnaire Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
